Skip to main content

Paul Ryan Touts The Benefits Of A Marijuana Ingredient And Industrial Hemp

Major late contributions are flowing into the coffers of Michigan and Missouri political action committees that have been set up to support or oppose marijuana ballot initiatives in those states, Marijuana Moment’s latest analysis of campaign finance data shows.

In Missouri, physician Bradley Bradshaw continues to pour money into the Find the Cures committee in support of Amendment 3. For October, since filing quarter three reports, the group reports $343,000 in contributions from Bradshaw in the form of loans. He had contributed $7,500 in cash in quarter three, and also provided $186,121 in loans. Find the Cures is also getting late support from legal firms, with five outfits contributing $45,000.

New Approach Missouri, which supports Amendment 2, reported that it had received $125,000 from Washington, D.C.-based New Approach PAC.

A committee set up to combat Bradshaw’s Measure 3, Patients Against Bradshaw Amendment Formally Known As Find The Cures Political Action Committee, reported only $757 in contributions in a filing made on Monday. Missourians For Patient Care reported no cash contributions in its “8 days before election” report, but disclosed a $450 contribution in a late contribution report.

In Michigan, the two largest marijuana initiative committees have seen a quarter-million dollars in contributions in just the last three days since quarter three figures were filed on Friday. The pro-legalization Coalition to Regulate Marijuana Like Alcohol officially reported a $25,000 donation that had been announced last week by the Drug Policy Alliance. National group New Approach is also a force here, donating an additional $58,650 to the committee over the weekend, bringing their October contributions in the state to over $300,000.

Meanwhile, the largest committee working against the initiative, Healthy and Productive Michigan, is reporting a sizable new contribution of $75,000 from national prohibition organization Smart Approaches to Marijuana, which has already provided over $1 million in cash and in-kind services to the effort. The prohibitionist committee also reported $100,000 from Dow Chemical Corporation.

DTE Energy executives continued to weigh in against the initiative, with David Meador, vice chairman of DTE Energy, and David Ruud, president of DTE Power & Industrial, each giving $2,500 to the anti-legalization committee. The group had already reported a total of $70,000 in donations from DTE Energy Chairman Gerard Anderson, company President and COO Jerry Norcia, DTE Electric President Trevor Lauer and DTE Gas President Mark Stiers.

In total, Healthy and Productive Michigan has racked up $310,000 in late contributions since October 20, while the Coalition to Regulate Marijuana Like Alcohol has brought in $151,150. For each committee, these new donations in the last nine days equal about one-third of their total cash previously raised in all of quarter three (August 20 – October 20).

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!

Original Article Source: https://www.marijuanamoment.net/paul-ryan-touts-the-benefits-of-a-marijuana-ingredient-and-industrial-hemp/

Comments

Popular posts from this blog

New York City Adds More Exceptions To Pre-Employment Marijuana Testing Ban

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the subs

Charlotte Figi The Girl Who Inspired A CBD Movement Has Died At Age 13

Charlotte had recently been hospitalized due to pneumonia, breathing problems and seizures. She was treated as a likely case of Covid-19, her mother, Paige Figi, said Wednesday, although she tested negative for the virus. “Charlotte is no longer suffering. She is seizure-free forever,” a family friend wrote on Paige Figi’s Facebook page, announcing Charlotte’s death. “Thank you so much for all of your love.” Charlotte became a symbol of the possibilities of CBD after CNN Chief Medical Correspondent Dr. Sanjay Gupta told her story in the documentary “Weed.” In the film, Charlotte was shown to be a playful child who was overcome by horrific seizures, which were quelled with Charlotte’s Web, a marijuana strain named in her honor. Charlotte had Dravet syndrome, a rare form of epilepsy which was not controlled by medication. The Stanley brothers, marijuana growers in Colorado, were crossbreeding a strain of marijuana high in CBD and low in THC, its psychoactive ingredient. After Charlo

Virginia CBD Program Criticized As Multistate Medical Cannabis Operators Gain Edge

Seven companies are challenging a CBD licensing process in Virginia that resulted in multistate medical marijuana operators getting a majority of available licenses. The appeals called the process “wildly prejudicial.” Out of 51 applicants for five vertically integrated CBD and THC-A licenses, multistate operators received three, a situation that spurred the appeals, The Virginian-Pilot reported. Applicants filing the appeals complained the closed-meeting review process lacked fairness and transparency. One consultant to an applicant said the selections felt “predetermined.” The Virginia Board of Pharmacy reportedly sent information to the applicants in December explaining its selections, but some applicants weren’t satisfied. A board spokeswoman wrote in an email to the Pilot that the board “does not comment on pending litigation.” The five winning applicants , called “pharmaceutical processors,” have a year from winning the licenses to become operational. The multistate